Traci Lyons
Concepts (213)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Breast Neoplasms | 22 | 2024 | 1965 | 4.090 |
Why?
| Semaphorins | 6 | 2021 | 22 | 3.550 |
Why?
| Antigens, CD | 7 | 2021 | 460 | 3.120 |
Why?
| Postpartum Period | 11 | 2022 | 271 | 2.620 |
Why?
| Cyclooxygenase 2 | 6 | 2020 | 168 | 2.290 |
Why?
| Lymphatic Vessels | 5 | 2024 | 54 | 2.080 |
Why?
| Mammary Glands, Human | 5 | 2024 | 61 | 1.970 |
Why?
| Mammary Glands, Animal | 7 | 2022 | 124 | 1.800 |
Why?
| Breast | 5 | 2022 | 140 | 1.350 |
Why?
| Gene Expression Regulation, Neoplastic | 6 | 2022 | 1167 | 1.160 |
Why?
| Epithelial Cells | 4 | 2024 | 963 | 1.140 |
Why?
| Lymphangiogenesis | 4 | 2024 | 23 | 1.050 |
Why?
| GPI-Linked Proteins | 6 | 2021 | 56 | 0.930 |
Why?
| Macrophages | 4 | 2020 | 1324 | 0.920 |
Why?
| Tumor Microenvironment | 8 | 2022 | 454 | 0.870 |
Why?
| Receptors, Estrogen | 3 | 2021 | 387 | 0.830 |
Why?
| Puerperal Disorders | 2 | 2014 | 33 | 0.830 |
Why?
| Anoikis | 1 | 2021 | 35 | 0.810 |
Why?
| Mammary Neoplasms, Animal | 3 | 2016 | 29 | 0.800 |
Why?
| Antineoplastic Agents, Hormonal | 2 | 2020 | 143 | 0.790 |
Why?
| Extracellular Matrix | 5 | 2021 | 446 | 0.780 |
Why?
| Drug Resistance, Neoplasm | 2 | 2021 | 671 | 0.700 |
Why?
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2019 | 219 | 0.630 |
Why?
| Cell Line, Tumor | 10 | 2021 | 2851 | 0.620 |
Why?
| Lactation | 4 | 2022 | 160 | 0.620 |
Why?
| Programmed Cell Death 1 Receptor | 1 | 2019 | 197 | 0.610 |
Why?
| Neoplasm Metastasis | 5 | 2020 | 544 | 0.560 |
Why?
| Mice | 17 | 2022 | 15520 | 0.550 |
Why?
| Carcinoma, Intraductal, Noninfiltrating | 1 | 2016 | 58 | 0.540 |
Why?
| NF-kappa B | 1 | 2019 | 670 | 0.540 |
Why?
| Neoplasm Recurrence, Local | 1 | 2020 | 900 | 0.520 |
Why?
| Biomarkers, Tumor | 2 | 2020 | 1059 | 0.520 |
Why?
| Proto-Oncogene Proteins c-akt | 3 | 2021 | 420 | 0.500 |
Why?
| Pregnancy Complications, Neoplastic | 3 | 2020 | 51 | 0.490 |
Why?
| Pregnancy | 10 | 2024 | 5690 | 0.460 |
Why?
| Xenograft Model Antitumor Assays | 4 | 2020 | 740 | 0.460 |
Why?
| Animals | 21 | 2022 | 33381 | 0.450 |
Why?
| Cell Movement | 6 | 2022 | 896 | 0.450 |
Why?
| Fibrillar Collagens | 1 | 2011 | 12 | 0.410 |
Why?
| Carcinoma, Ductal | 1 | 2011 | 12 | 0.410 |
Why?
| Female | 25 | 2024 | 61564 | 0.410 |
Why?
| Disease Models, Animal | 5 | 2020 | 3730 | 0.400 |
Why?
| Mice, Inbred BALB C | 3 | 2019 | 1206 | 0.380 |
Why?
| Neoplasm Invasiveness | 5 | 2020 | 462 | 0.350 |
Why?
| Antigens, Differentiation, Myelomonocytic | 2 | 2019 | 55 | 0.340 |
Why?
| Cell Survival | 2 | 2021 | 1047 | 0.300 |
Why?
| Humans | 28 | 2024 | 118972 | 0.300 |
Why?
| Mice, Inbred C57BL | 4 | 2021 | 4908 | 0.290 |
Why?
| Membrane Glycoproteins | 2 | 2019 | 446 | 0.290 |
Why?
| Ubiquitin-Protein Ligases | 1 | 2007 | 148 | 0.280 |
Why?
| Prognosis | 4 | 2020 | 3443 | 0.280 |
Why?
| Mice, SCID | 2 | 2020 | 333 | 0.280 |
Why?
| Cell Transformation, Neoplastic | 2 | 2021 | 317 | 0.270 |
Why?
| Mice, Inbred NOD | 3 | 2021 | 574 | 0.250 |
Why?
| Apoptosis | 2 | 2020 | 2484 | 0.250 |
Why?
| Mice, Knockout | 3 | 2022 | 2680 | 0.250 |
Why?
| Celecoxib | 2 | 2014 | 38 | 0.230 |
Why?
| Head and Neck Neoplasms | 2 | 2020 | 471 | 0.220 |
Why?
| Disease-Free Survival | 2 | 2021 | 649 | 0.220 |
Why?
| Immune Evasion | 1 | 2022 | 48 | 0.220 |
Why?
| Receptors, CXCR3 | 1 | 2022 | 16 | 0.210 |
Why?
| Disease Progression | 3 | 2020 | 2490 | 0.210 |
Why?
| Chemokine CXCL9 | 1 | 2022 | 22 | 0.210 |
Why?
| Integrin alpha6 | 1 | 2021 | 6 | 0.210 |
Why?
| Caspase 7 | 1 | 2021 | 23 | 0.210 |
Why?
| Chemokine CXCL10 | 1 | 2022 | 40 | 0.210 |
Why?
| Integrin beta1 | 1 | 2021 | 20 | 0.210 |
Why?
| Immunohistochemistry | 2 | 2019 | 1691 | 0.210 |
Why?
| Gene Knockdown Techniques | 2 | 2020 | 311 | 0.200 |
Why?
| Fibronectins | 2 | 2020 | 114 | 0.190 |
Why?
| Focal Adhesion Protein-Tyrosine Kinases | 1 | 2020 | 26 | 0.190 |
Why?
| Mammals | 1 | 2022 | 253 | 0.190 |
Why?
| Caspase 3 | 1 | 2021 | 243 | 0.190 |
Why?
| Melanoma, Experimental | 1 | 2022 | 118 | 0.190 |
Why?
| Cytoskeletal Proteins | 1 | 2021 | 146 | 0.190 |
Why?
| Actin Cytoskeleton | 1 | 2021 | 100 | 0.190 |
Why?
| Hyaluronan Receptors | 1 | 2020 | 93 | 0.190 |
Why?
| Receptors, G-Protein-Coupled | 1 | 2022 | 200 | 0.180 |
Why?
| Adipocytes | 1 | 2021 | 199 | 0.180 |
Why?
| Lymphatic Metastasis | 3 | 2019 | 307 | 0.180 |
Why?
| Pyrazoles | 2 | 2014 | 363 | 0.180 |
Why?
| Maternal Age | 1 | 2020 | 122 | 0.180 |
Why?
| Extracellular Vesicles | 1 | 2020 | 76 | 0.180 |
Why?
| Models, Biological | 3 | 2019 | 1715 | 0.180 |
Why?
| Sulfonamides | 2 | 2014 | 445 | 0.180 |
Why?
| Enzyme Activation | 1 | 2021 | 828 | 0.180 |
Why?
| Kaplan-Meier Estimate | 2 | 2020 | 842 | 0.180 |
Why?
| Estrogens | 2 | 2020 | 328 | 0.180 |
Why?
| Signal Transduction | 5 | 2022 | 4709 | 0.170 |
Why?
| Collagen | 2 | 2013 | 433 | 0.170 |
Why?
| Mammary Neoplasms, Experimental | 1 | 2019 | 63 | 0.170 |
Why?
| Genes, Reporter | 1 | 2019 | 270 | 0.170 |
Why?
| Actins | 1 | 2021 | 404 | 0.170 |
Why?
| Tumor Cells, Cultured | 1 | 2020 | 874 | 0.170 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2011 | 982 | 0.170 |
Why?
| Crosses, Genetic | 1 | 2018 | 138 | 0.160 |
Why?
| Phosphorylation | 2 | 2021 | 1633 | 0.160 |
Why?
| Integrins | 1 | 2018 | 82 | 0.160 |
Why?
| Cell Proliferation | 3 | 2020 | 2275 | 0.160 |
Why?
| B7-H1 Antigen | 1 | 2019 | 144 | 0.150 |
Why?
| Protein Binding | 2 | 2022 | 1975 | 0.150 |
Why?
| RNA, Small Interfering | 1 | 2020 | 564 | 0.150 |
Why?
| Podosomes | 1 | 2016 | 3 | 0.150 |
Why?
| Neoplastic Stem Cells | 1 | 2020 | 336 | 0.140 |
Why?
| Adaptor Proteins, Vesicular Transport | 1 | 2016 | 48 | 0.140 |
Why?
| Survival Rate | 1 | 2020 | 1720 | 0.140 |
Why?
| rab GTP-Binding Proteins | 1 | 2016 | 64 | 0.140 |
Why?
| Genetic Pleiotropy | 1 | 2016 | 31 | 0.140 |
Why?
| Protein Kinase Inhibitors | 1 | 2021 | 811 | 0.140 |
Why?
| Melanoma | 1 | 2022 | 664 | 0.130 |
Why?
| Phenotype | 2 | 2021 | 3003 | 0.130 |
Why?
| Skin Neoplasms | 1 | 2022 | 762 | 0.120 |
Why?
| CD8-Positive T-Lymphocytes | 1 | 2019 | 702 | 0.120 |
Why?
| Dinoprostone | 1 | 2014 | 193 | 0.120 |
Why?
| Blotting, Western | 3 | 2011 | 1194 | 0.120 |
Why?
| CD4-Positive T-Lymphocytes | 1 | 2019 | 984 | 0.110 |
Why?
| Endothelial Cells | 1 | 2018 | 732 | 0.110 |
Why?
| Carcinoma, Ductal, Breast | 1 | 2013 | 91 | 0.110 |
Why?
| Drug Design | 1 | 2013 | 160 | 0.110 |
Why?
| Hematopoietic Stem Cells | 1 | 2015 | 359 | 0.100 |
Why?
| Ibuprofen | 1 | 2011 | 76 | 0.100 |
Why?
| In Situ Hybridization, Fluorescence | 1 | 2011 | 310 | 0.090 |
Why?
| Risk | 2 | 2013 | 853 | 0.090 |
Why?
| Time Factors | 4 | 2020 | 6412 | 0.090 |
Why?
| BRCA1 Protein | 1 | 2010 | 57 | 0.090 |
Why?
| Cohort Studies | 1 | 2020 | 5116 | 0.090 |
Why?
| Mutation | 1 | 2019 | 3457 | 0.080 |
Why?
| Macrophage Activation | 1 | 2010 | 168 | 0.080 |
Why?
| Stromal Cells | 1 | 2009 | 102 | 0.080 |
Why?
| Incidence | 2 | 2020 | 2424 | 0.080 |
Why?
| Analysis of Variance | 1 | 2011 | 1293 | 0.080 |
Why?
| Extracellular Matrix Proteins | 1 | 2009 | 133 | 0.080 |
Why?
| Tamoxifen | 1 | 2009 | 198 | 0.080 |
Why?
| Gonadal Steroid Hormones | 1 | 2009 | 122 | 0.080 |
Why?
| Insulin-Like Growth Factor I | 1 | 2010 | 287 | 0.080 |
Why?
| Restriction Mapping | 1 | 2007 | 76 | 0.080 |
Why?
| Intercellular Signaling Peptides and Proteins | 1 | 2009 | 369 | 0.070 |
Why?
| Disease Susceptibility | 1 | 2009 | 331 | 0.070 |
Why?
| Estradiol | 1 | 2010 | 476 | 0.070 |
Why?
| Cloning, Molecular | 1 | 2007 | 546 | 0.070 |
Why?
| Male | 3 | 2021 | 57801 | 0.070 |
Why?
| Cell Line | 2 | 2010 | 2707 | 0.070 |
Why?
| Immunotherapy | 2 | 2022 | 493 | 0.060 |
Why?
| Recombinant Fusion Proteins | 1 | 2007 | 653 | 0.060 |
Why?
| Young Adult | 3 | 2020 | 10793 | 0.060 |
Why?
| Phosphatidylinositol 3-Kinases | 2 | 2020 | 341 | 0.060 |
Why?
| Adult | 6 | 2020 | 31512 | 0.060 |
Why?
| Base Sequence | 1 | 2007 | 2159 | 0.060 |
Why?
| Neoplasms | 1 | 2016 | 2179 | 0.050 |
Why?
| Molecular Sequence Data | 1 | 2007 | 2871 | 0.050 |
Why?
| Cell Cycle Proteins | 2 | 2020 | 565 | 0.050 |
Why?
| Antineoplastic Agents | 1 | 2013 | 1974 | 0.050 |
Why?
| Stress Fibers | 1 | 2021 | 18 | 0.050 |
Why?
| T-Lymphocytes, Cytotoxic | 1 | 2022 | 158 | 0.050 |
Why?
| Lymphocytes, Tumor-Infiltrating | 1 | 2022 | 112 | 0.050 |
Why?
| Focal Adhesions | 1 | 2021 | 44 | 0.050 |
Why?
| Tumor Burden | 1 | 2022 | 274 | 0.050 |
Why?
| Zinc Finger E-box-Binding Homeobox 1 | 1 | 2020 | 25 | 0.050 |
Why?
| Feedback, Physiological | 1 | 2020 | 75 | 0.050 |
Why?
| Pregnancy-Associated Plasma Protein-A | 1 | 2020 | 14 | 0.050 |
Why?
| SOXB1 Transcription Factors | 1 | 2020 | 61 | 0.050 |
Why?
| Proteomics | 2 | 2020 | 876 | 0.050 |
Why?
| Kidney | 1 | 2007 | 1353 | 0.040 |
Why?
| Cell Adhesion | 1 | 2020 | 443 | 0.040 |
Why?
| Cell Communication | 1 | 2020 | 281 | 0.040 |
Why?
| Parity | 1 | 2019 | 101 | 0.040 |
Why?
| Hyaluronic Acid | 1 | 2020 | 197 | 0.040 |
Why?
| Ki-67 Antigen | 1 | 2019 | 108 | 0.040 |
Why?
| Survival Analysis | 1 | 2022 | 1267 | 0.040 |
Why?
| Rats | 3 | 2013 | 5392 | 0.040 |
Why?
| Adaptor Proteins, Signal Transducing | 1 | 2020 | 394 | 0.040 |
Why?
| Global Health | 1 | 2020 | 310 | 0.040 |
Why?
| Monocytes | 1 | 2020 | 513 | 0.040 |
Why?
| Matrix Metalloproteinase 2 | 1 | 2016 | 56 | 0.040 |
Why?
| Neoplasm Proteins | 1 | 2020 | 401 | 0.040 |
Why?
| Breast Feeding | 1 | 2020 | 386 | 0.040 |
Why?
| Matrix Metalloproteinase 9 | 1 | 2016 | 127 | 0.030 |
Why?
| Lymph Nodes | 1 | 2019 | 455 | 0.030 |
Why?
| Protein Domains | 1 | 2016 | 212 | 0.030 |
Why?
| Neoplasm Staging | 1 | 2019 | 1223 | 0.030 |
Why?
| Rats, Sprague-Dawley | 2 | 2010 | 2478 | 0.030 |
Why?
| Gene Expression Profiling | 1 | 2020 | 1597 | 0.030 |
Why?
| Bone Marrow | 1 | 2015 | 255 | 0.030 |
Why?
| Case-Control Studies | 1 | 2020 | 3171 | 0.030 |
Why?
| Middle Aged | 3 | 2020 | 27617 | 0.030 |
Why?
| Risk Factors | 2 | 2019 | 9000 | 0.030 |
Why?
| Cadherins | 1 | 2013 | 186 | 0.030 |
Why?
| Liver | 1 | 2020 | 1816 | 0.030 |
Why?
| Weaning | 1 | 2010 | 57 | 0.020 |
Why?
| MicroRNAs | 1 | 2016 | 637 | 0.020 |
Why?
| Receptor, IGF Type 1 | 1 | 2010 | 59 | 0.020 |
Why?
| Proportional Hazards Models | 1 | 2013 | 1125 | 0.020 |
Why?
| Immunoprecipitation | 1 | 2010 | 161 | 0.020 |
Why?
| Proteasome Endopeptidase Complex | 1 | 2010 | 139 | 0.020 |
Why?
| Matrix Metalloproteinases | 1 | 2010 | 90 | 0.020 |
Why?
| Mitogen-Activated Protein Kinase 1 | 1 | 2010 | 173 | 0.020 |
Why?
| Multivariate Analysis | 1 | 2013 | 1474 | 0.020 |
Why?
| Fluorescent Antibody Technique | 1 | 2010 | 410 | 0.020 |
Why?
| Biomarkers | 2 | 2010 | 3588 | 0.020 |
Why?
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2009 | 146 | 0.020 |
Why?
| Species Specificity | 1 | 2010 | 565 | 0.020 |
Why?
| Protein Transport | 1 | 2010 | 412 | 0.020 |
Why?
| Cytokines | 1 | 2015 | 1900 | 0.020 |
Why?
| Mice, Nude | 1 | 2009 | 663 | 0.020 |
Why?
| Cell Cycle | 1 | 2010 | 550 | 0.020 |
Why?
| Cell Culture Techniques | 1 | 2009 | 356 | 0.020 |
Why?
| Mass Spectrometry | 1 | 2010 | 681 | 0.020 |
Why?
| Recombinant Proteins | 1 | 2010 | 1308 | 0.020 |
Why?
| Fibroblasts | 1 | 2009 | 842 | 0.020 |
Why?
| Adolescent | 1 | 2020 | 18480 | 0.010 |
Why?
| Cells, Cultured | 1 | 2010 | 4077 | 0.010 |
Why?
| Retrospective Studies | 1 | 2013 | 12978 | 0.010 |
Why?
| Aged | 1 | 2010 | 19657 | 0.010 |
Why?
|
|
Lyons's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|